About
About Charleroi Treatment Services
Co-occurring disorders — the intersection of a substance use condition and a diagnosable mental health condition — are at the center of what Charleroi Treatment Services addresses. Situated at 15 Arentzen Boulevard in Charleroi, Pennsylvania, in Washington County, the program holds accreditation from four independent bodies: the Joint Commission, CARF, the Council on Accreditation, and NCQA. That depth of external review is notable for a substance use treatment program of this scope.
Two distinct levels of care are available at the program. Medical detox represents the clinically intensive entry point, providing medically supervised withdrawal management for people whose physical dependence requires professional oversight before other treatment can begin. In the broader field, medical detox occupies the highest-acuity position on an outpatient-to-residential continuum, with its primary purpose being to stabilize a patient’s physical condition safely. Alongside medical detox, an outpatient program allows people to engage in structured treatment while continuing to live in the community — a meaningful option for those whose circumstances call for flexibility.
The center carries an Opioid Treatment Program certification, which situates opioid use disorder squarely within its clinical scope. Cognitive Behavioral Therapy is a therapeutic method in use. Services are conducted in English. The combination of dual diagnosis treatment capacity and an OTP certification means the program is equipped to address both the psychiatric and the substance-specific dimensions of opioid dependence within the same treatment setting.
Payment access is equally wide, spanning Medicaid, Medicare, TRICARE, private insurance, state insurance, and self-pay. The program’s four independent accreditations provide external assurance of quality that families and referring providers can weigh when making treatment decisions.
- Opioid Treatment Program (OTP) certification supporting medically supervised opioid withdrawal management
- Accredited by four independent bodies: Joint Commission, CARF, Council on Accreditation, and NCQA
- Dual diagnosis treatment addressing co-occurring substance use and mental health conditions
- Broad population reach including veterans, pregnant women, seniors, and court-ordered individuals
- Multiple payment pathways: Medicaid, Medicare, TRICARE, private insurance, state insurance, and self-pay